The strategy’s diversified, flexible-growth strategy has strengths, but its massive asset base and individual position caps limit some of its flexibility. It warrants an Average Process rating.
Robust research capabilities back this strategy, with 12 disclosed managers and three analyst teams running separate portfolio sleeves here. The managers search for opportunities globally; some of them prefer traditional growth stocks, others fallen angels, and even cyclical names, though all take long-term views. This diversity leads to a differentiated portfolio across sectors and companies, allowing the strategy to benefit from varied market conditions.
Yet that diverse approach makes it a challenging fit within the large-growth category. For example, stock positions here rarely get larger than 6%-7% of assets. Granted, that’s more similar to its S&P 500 prospectus index but substantially different from the Russell 1000 Growth Index, which had three companies with more than 10% of assets each as of December 2025. The strategy held only 37% of assets in its top 10 holdings, landing it in the lowest decile of large-growth peers, and was substantially lower than the category index’s 61%. As mega-caps continue to drive market returns, this differentiation means the managers must hit on more companies to outperform the index.
Additionally, the strategy’s massive USD 335 billion asset base limits its flexibility and makes it difficult for one-off positions in small- and mid-cap firms to have an impact at the portfolio level. Granted, with the median size of each manager’s sleeve around USD 24 billion, investing in smaller companies isn’t a problem at the sleeve level. But such weightings get diluted as the various sleeves coalesce.
The strategy holds a diverse portfolio of roughly 330 stocks spread across market sectors, which has helped limit volatility over time. So, too, has its cash stake, which has typically been less than 7% of assets the past five years, but has risen to roughly 15% during periods of market stress.
Company-level research drives the strategy’s sector positioning, which often stands out from those of the Russell 1000 Growth Index category benchmark. For instance, the strategy has kept a double-digit tech underweighting over the past five years and was nearly 23 percentage points below the category benchmark at year-end 2025. To be sure, several of the strategy’s top internet holdings, such as Meta Platforms and Google's parent Alphabet, were previously considered tech holdings. Yet the managers have mostly avoided Apple, which is one of the world’s largest firms by market cap and tallied 11% of the index’s market value as of December 2025.
The strategy’s sector positioning more closely resembles its S&P 500 prospectus benchmark. As of December 2025, it held roughly 10%-15% of assets each in consumer discretionary, healthcare, industrials, financials, and communication services.
With roughly USD 330 billion in assets, the strategy is the large-growth category’s biggest active offering. That heft limits its ability to take big positions in mid-cap and even some large-cap stocks.